Translated from our German original by AI. The German text was researched, written, and edited by the Psychedelia Foundation team and remains the authoritative version.
A recent scientific analysis examines the health effects of naturalistic psychedelic use, that is, use outside clinical trials and medically controlled research settings (recreational use). The study “Beyond prohibition: A public health analysis of naturalistic psychedelic use” draws on an assessment of 104 peer-reviewed articles and considers possible psychological, physical, and social effects of various substances, among them psilocybin, LSD, MDMA, mescaline, and 5-MeO-DMT.
The authors report that naturalistic psychedelic use was associated with a range of positive health and social outcomes in the studies assessed. These include lower levels of depression, anxiety, post-traumatic stress disorder (PTSD), problematic substance use, and suicidality. Associations were also described with improved emotional well-being, stronger social connectedness, greater psychological flexibility, a closer connection to nature, and positive changes in personal experiences of meaning and spirituality.
According to the analysis, the associations observed were found across different populations and countries. These include people with experiences of trauma, addiction, or chronic pain, as well as older people and marginalised groups.
At the same time, the study points to possible risks. Adverse effects can occur and are, according to the authors, linked in particular to factors such as young age, high doses, psychological vulnerability, and unfavourable conditions of use (“set and setting”). The analysis stresses that careful preparation, suitable conditions, and education can help to reduce risks.
On the basis of the data assessed, the study argues for a shift away from a purely prohibition-based approach to psychedelics towards a public health approach that takes scientific evidence, prevention, risk reduction, and regulated access models into account.
The authors conclude that evidence-based education, safety standards, and greater attention to health policy could be a more suitable way of dealing with psychedelics than a sole focus on prohibition. In their assessment, the findings argue for further scientific study and a public debate on regulation and harm reduction.
